IL-1β is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence

Neurobiol Dis. 2011 Dec;44(3):259-69. doi: 10.1016/j.nbd.2011.05.015. Epub 2011 May 30.

Abstract

Interleukin (IL)-1β plays a crucial role in the mechanisms of limbic seizures in rodent models of temporal lobe epilepsy. We addressed whether activation of the IL-1β signaling occurs in rats with genetic absence epilepsy (GAERS) during the development of spike-and-wave discharges (SWDs). Moreover, we studied whether inhibition of IL-1β biosynthesis in GAERS could affect SWD activity. IL-1β expression and glia activation were studied by immunocytochemistry in the forebrain of GAERS at postnatal days (PN)14, PN20, and PN90 and in age-matched non-epileptic control Wistar rats. In PN14 GAERS, when no SWDs have developed yet, IL-1β immunostaining was undetectable, and astrocytes and microglia showed a resting phenotype similar to control Wistar rats. In 3 out of 9 PN20 GAERS, IL-1β was observed in activated astrocytes of the somatosensory cortex; the cytokine expression was associated with the occurrence of immature-type of SWDs. In all adult PN90 GAERS, when mature SWDs are established, IL-1β was observed in reactive astrocytes of the somatosensory cortex but not in adjacent cortical areas or in extra-cortical regions. An age-dependent c-fos activation was found in the somatosensory cortex of GAERS with maximal levels reached in PN90 rats; c-fos was also induced in some thalamic nuclei in PN20 and PN90 GAERS. Inhibition of IL-1β biosynthesis in PN90 GAERS by 4-day systemic administration of a specific ICE/Caspase-1 blocker, significantly reduced both SWD number and duration. These results show that IL-1β is induced in reactive astrocytes of the somatosensory cortex of GAERS at the onset of SWDs. IL-1β has pro-ictogenic properties in this model, and thus it may play a contributing role in the mechanisms underlying the occurrence of absence seizures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Aminobenzoic Acid / pharmacology
  • Age Factors
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Astrocytes / drug effects
  • Astrocytes / metabolism*
  • Brain Waves / drug effects
  • Brain Waves / genetics
  • Brain Waves / physiology*
  • Cell Count
  • Dipeptides / pharmacology
  • Disease Models, Animal
  • Electroencephalography
  • Enzyme Inhibitors / pharmacology
  • Epilepsy, Absence / genetics
  • Epilepsy, Absence / pathology*
  • Epilepsy, Absence / physiopathology*
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Expression Regulation, Developmental / genetics
  • Gene Expression Regulation, Developmental / physiology
  • Glial Fibrillary Acidic Protein / metabolism
  • Interleukin-1beta / metabolism*
  • Male
  • Proto-Oncogene Proteins c-fos / metabolism
  • Rats
  • Rats, Mutant Strains
  • Rats, Wistar
  • Somatosensory Cortex / metabolism
  • Somatosensory Cortex / pathology*
  • Statistics, Nonparametric
  • Thalamic Nuclei / cytology
  • Thalamic Nuclei / metabolism
  • para-Aminobenzoates

Substances

  • Dipeptides
  • Enzyme Inhibitors
  • Glial Fibrillary Acidic Protein
  • Interleukin-1beta
  • Proto-Oncogene Proteins c-fos
  • para-Aminobenzoates
  • belnacasan
  • 4-Aminobenzoic Acid